PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-6.75
Negative P/E while Healthcare median is -1.17. Seth Klarman would scrutinize path to profitability versus peers.
6.83
P/S near Healthcare median of 6.59. Charlie Munger would examine if similar pricing reflects similar economics.
0.39
P/B less than half the Healthcare median of 1.83. Joel Greenblatt would investigate if assets are truly impaired. Check ROE versus peers.
-36.47
Negative FCF while Healthcare median P/FCF is -4.28. Seth Klarman would investigate cash flow improvement potential.
-43.50
Negative operating cash flow while Healthcare median P/OCF is -2.90. Seth Klarman would investigate operational improvement potential.
0.39
Fair value ratio less than half the Healthcare median of 1.85. Joel Greenblatt would investigate if this discount is justified.
-3.71%
Negative earnings while Healthcare median yield is -2.41%. Seth Klarman would investigate path to profitability.
-2.74%
Negative FCF while Healthcare median yield is -1.53%. Seth Klarman would investigate cash flow improvement potential.
